Why Korea Is Now More Attractive To U.S. Biopharma
Source: Life Science Leader
By Sungho Han, Ph.D.
By most measures, South Korea is an attractive market for pharma companies. The population, around 51 million, is roughly equal to California and North Carolina combined. Healthcare spending per capita is rising. Seniors — who account for higher pharmaceutical spending than other demographics — make up more than 16% of the population. Ranked by total spending, South Korea is among the top 15 markets for pharmaceutical sales.
VIEW THE MAGAZINE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Life Science Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more